TM9SF4 inhibitors belong to a class of chemical compounds designed to selectively target and modulate the activity of the transmembrane 9 superfamily member 4 protein, abbreviated as TM9SF4. TM9SF4 is a transmembrane protein that is primarily localized within the endosomal and lysosomal compartments of cells. While the precise function of TM9SF4 is still not fully understood, it is believed to be involved in various cellular processes related to vesicular trafficking, endosomal maturation, and intracellular membrane dynamics. TM9SF4 inhibitors are developed through chemical synthesis and structural optimization techniques, with the primary goal of interacting with specific domains or functional motifs of the TM9SF4 protein to influence its cellular functions.
The design of TM9SF4 inhibitors typically involves creating molecules that can selectively bind to TM9SF4, potentially interfering with its interactions with other cellular components or affecting its role in endosomal and lysosomal processes. By modulating TM9SF4 activity, these inhibitors have the potential to impact vesicular trafficking, membrane dynamics, and cellular compartmentalization, providing valuable insights into the molecular mechanisms governing intracellular membrane organization and transport. The study of TM9SF4 inhibitors contributes to our understanding of the intricate processes underlying intracellular membrane dynamics and vesicular trafficking, offering a deeper insight into the fundamental processes that regulate organelle biogenesis and cellular compartmentalization. This research advances our knowledge of basic cell biology and the regulatory networks that maintain cellular structure and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, rapamycin affects cell growth and autophagy, potentially influencing TM9SF4 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, LY294002 can modulate several signaling pathways, potentially influencing TM9SF4 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, wortmannin affects various signaling pathways, potentially impacting TM9SF4 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, trichostatin A affects chromatin structure and gene expression, potentially influencing TM9SF4 expression. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A kinase inhibitor, staurosporine can affect multiple signaling pathways, potentially impacting TM9SF4 expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits the TGF-β receptor, potentially affecting signaling pathways and gene expression, including TM9SF4. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, SP600125 could potentially modulate signaling pathways that influence TM9SF4 expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, bortezomib can affect various cellular pathways, potentially influencing TM9SF4 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Interferes with lysosomal function and autophagy, potentially affecting TM9SF4 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An ERK inhibitor, PD98059 might affect pathways involved in cell signaling and gene expression, including TM9SF4. | ||||||